We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$40.9M
Cap. Flow
+$30.7M
Cap. Flow %
14.18%
Top 10 Hldgs %
40.9%
Holding
110
New
40
Increased
20
Reduced
11
Closed
36

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.41M
2
BIIB icon
Biogen
BIIB
+$4.44M
3
CI icon
Cigna
CI
+$3.91M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.61M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.18M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$3.56M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.4M
3
GILD icon
Gilead Sciences
GILD
+$2.74M
4
ITMN
INTERMUNE INC
ITMN
+$2.21M
5
DXCM icon
DexCom
DXCM
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THOR
101
DELISTED
THORATEC CORPORATION
THOR
– –
-30,000
Closed -$1.1M
TRNX
102
CALL
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-250,000
Closed -$4.36M
NPSP
103
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-45,000
Closed -$1.37M
ITMN
104
DELISTED
INTERMUNE INC
ITMN
– –
-150,000
Closed -$2.21M
FRX
105
CALL
DELISTED
FOREST LABORATORIES INC
FRX
– –
-50,000
Closed -$2.81M
ARTC
106
DELISTED
ARTHROCARE CORP
ARTC
– –
-75,000
Closed -$3.56M
CADX
107
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
– –
-50,000
Closed -$453K
SLTM
108
DELISTED
SOLTA MED INC (DE)
SLTM
– –
-175,000
Closed -$516K
COV
109
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-50,000
Closed -$3.4M
MDVN
110
DELISTED
MEDIVATION, INC.
MDVN
– –
-30,000
Closed -$957K
1 2 3 4
5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2014 Portfolio in Review

As of Q1 2014, Iguana Healthcare Management held 110 positions worth $216M, up 23% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management deployed $30.7M of net new capital in Q1 2014, opening 40 new positions and adding to 20 existing holdings. Its largest new stake was Medtronic: 110,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.74M trimmed.

  • Iguana Healthcare Management's largest Q1 2014 buy was Medtronic: 110,000 shares worth $6.77M.
  • Iguana Healthcare Management added most to Biogen in Q1 2014, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q1 2014 reduction was Gilead Sciences, cutting an estimated $2.74M.
  • Iguana Healthcare Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $3.56M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $216M portfolio in Q1 2014.
  • Iguana Healthcare Management opened 40 new positions and closed 36 in Q1 2014.
  • Iguana Healthcare Management's portfolio value rose 23% quarter-over-quarter to $216M.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.